Indian Orthopedic Biomaterials Markets
The Indian orthopedic biomaterials market is expected to reach $71.6 million by 2019. The bone graft substitute segment constitutes the majority of the Indian orthopedic biomaterials market, and is the fastest growing segment.
The Indian orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented into allografts, synthetics and demineralized bone matrices) and hyaluronic acid (HA) viscosupplementation. The overall market is still relatively young in India and is expected to continue to grow as a result of the aging Indian population and as new competitors enter the market. Further growth in the overall market is fuelled by the Indian government’s efforts to improve healthcare coverage across the country, and by the increasing disposable income of Indian citizens.
Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for India.
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
The Indian orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented into allografts, synthetics and demineralized bone matrices) and hyaluronic acid (HA) viscosupplementation. The overall market is still relatively young in India and is expected to continue to grow as a result of the aging Indian population and as new competitors enter the market. Further growth in the overall market is fuelled by the Indian government’s efforts to improve healthcare coverage across the country, and by the increasing disposable income of Indian citizens.
Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for India.
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
EXECUTIVE SUMMARY
1.1 INDIAN MARKET FOR ORTHOPEDIC BIOMATERIALS
1.2 GROWTH TRENDS BY SEGMENT
1.3 PROCEDURES
1.4 BONE GRAFT SUBSTITUTE MARKET
1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.6 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
INDIAN ORTHOPEDIC BIOMATERIALS MARKET
3.1 INTRODUCTION
3.1.1 Growth Factors
3.1.2 Bone Graft Substitutes
3.1.3 Hyaluronic Acid Viscosupplementation
3.2 CURRENCY EXCHANGE RATE
3.3 PROCEDURES
3.3.1 Total Orthopedic Bone Graft Substitute Procedures by Indication
3.3.2 Total Orthopedic Bone Graft Substitute Procedures by Segment
3.3.3 Bone Graft Substitute Procedures
3.3.4 Hyaluronic Acid Viscosupplementation Procedures
3.4MARKET OVERVIEW
3.5 TREND ANALYSIS
3.6MARKET DRIVERS AND LIMITERS
3.6.1 Market Drivers
3.6.2 Market Limiters
3.7 COMPETITIVE ANALYSIS
3.7.1 Leading Competitors
3.7.2 Market Concentration
3.8MERGERS AND ACQUISITIONS
BONE GRAFT SUBSTITUTE MARKET
4.1 INTRODUCTION
4.1.1.1 Autograft
4.1.1.2 Non-Proprietary Allograft
4.1.1.3 Demineralized Bone Matrix
4.1.1.4 Synthetic
4.1.2 Volumes Represented per Procedure
4.2MARKET OVERVIEW
4.3MARKET ANALYSIS & FORECAST
4.3.1 Allograft Market
4.3.1.1 Total Allograft Market
4.3.2 Synthetic Market
4.3.2.1 Total Synthetic Market
4.3.3 Demineralized Bone Matrix Market
4.3.3.1 Total DBM Market
4.3.4 Market by Indication
4.3.5 Cervical Market
4.3.6 Thoracolumbar Market
4.3.7 Trauma & Reconstruction Market
4.3.8 Craniomaxillofacial Market
4.3.8.1 Craniomaxillofacial Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE ANALYSIS
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
5.1 INTRODUCTION
5.1.1.1 Single-Injection Products
5.1.1.2 Three-Injection Cycle Products
5.1.1.3 Five-Injection Cycle Products
5.2MARKET OVERVIEW
5.3MARKET ANALYSIS & FORECAST
5.3.1 Single Injection Market
5.3.2 Three Injection Cycle Market
5.3.3 Five Injection Cycle Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
APPENDIX: (OPTIONAL)
ABBREVIATIONS
1.1 INDIAN MARKET FOR ORTHOPEDIC BIOMATERIALS
1.2 GROWTH TRENDS BY SEGMENT
1.3 PROCEDURES
1.4 BONE GRAFT SUBSTITUTE MARKET
1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.6 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
INDIAN ORTHOPEDIC BIOMATERIALS MARKET
3.1 INTRODUCTION
3.1.1 Growth Factors
3.1.2 Bone Graft Substitutes
3.1.3 Hyaluronic Acid Viscosupplementation
3.2 CURRENCY EXCHANGE RATE
3.3 PROCEDURES
3.3.1 Total Orthopedic Bone Graft Substitute Procedures by Indication
3.3.2 Total Orthopedic Bone Graft Substitute Procedures by Segment
3.3.3 Bone Graft Substitute Procedures
3.3.4 Hyaluronic Acid Viscosupplementation Procedures
3.4MARKET OVERVIEW
3.5 TREND ANALYSIS
3.6MARKET DRIVERS AND LIMITERS
3.6.1 Market Drivers
3.6.2 Market Limiters
3.7 COMPETITIVE ANALYSIS
3.7.1 Leading Competitors
3.7.2 Market Concentration
3.8MERGERS AND ACQUISITIONS
BONE GRAFT SUBSTITUTE MARKET
4.1 INTRODUCTION
4.1.1.1 Autograft
4.1.1.2 Non-Proprietary Allograft
4.1.1.3 Demineralized Bone Matrix
4.1.1.4 Synthetic
4.1.2 Volumes Represented per Procedure
4.2MARKET OVERVIEW
4.3MARKET ANALYSIS & FORECAST
4.3.1 Allograft Market
4.3.1.1 Total Allograft Market
4.3.2 Synthetic Market
4.3.2.1 Total Synthetic Market
4.3.3 Demineralized Bone Matrix Market
4.3.3.1 Total DBM Market
4.3.4 Market by Indication
4.3.5 Cervical Market
4.3.6 Thoracolumbar Market
4.3.7 Trauma & Reconstruction Market
4.3.8 Craniomaxillofacial Market
4.3.8.1 Craniomaxillofacial Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE ANALYSIS
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
5.1 INTRODUCTION
5.1.1.1 Single-Injection Products
5.1.1.2 Three-Injection Cycle Products
5.1.1.3 Five-Injection Cycle Products
5.2MARKET OVERVIEW
5.3MARKET ANALYSIS & FORECAST
5.3.1 Single Injection Market
5.3.2 Three Injection Cycle Market
5.3.3 Five Injection Cycle Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
APPENDIX: (OPTIONAL)
ABBREVIATIONS
